Sword Health
Sword Health is a digital health company providing AI-supported physical therapy and other virtual care programs for musculoskeletal, pelvic health, pain management, injury prevention, and surgical preparation.
Last updated August 24, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Sword Health is a privately held digital health company founded in Portugal in 2015 by biomedical engineer Virgílio Bento and Márcio Colunas. The company develops technology-enabled rehabilitation and physical therapy programs intended to help people manage pain, improve movement, avoid preventable procedures, and recover from injury or surgery. Its core model combines software, wearable motion sensors, clinical guidance, educational content, and artificial intelligence-assisted feedback rather than relying solely on in-person therapy. Sword initially focused on digital rehabilitation for musculoskeletal conditions, a broad category that includes back, neck, joint, and other movement-related problems. Early development centered on wearable sensors that could capture movement and an AI-driven platform that could help assess exercises and provide feedback. The company tested prototypes and feasibility applications during the late 2010s, then expanded beyond Portugal through pilot programs, a U.S. office, employer relationships, and health-plan distribution. Its commercial model has generally emphasized access through employers, insurers, and healthcare benefit programs rather than only direct consumer sales. From 2020 through 2022, Sword expanded its funding base, clinical organization, and product scope. It introduced or developed programs aimed at assessing the risk of musculoskeletal surgery and identifying conservative treatment options. The company also broadened its addressable market beyond general musculoskeletal therapy. Bloom, launched in 2022, addressed pelvic health, including pelvic-floor dysfunction and postpartum recovery. Move focused on movement health and injury prevention, while later services addressed pain education, clinical access, and preparation for surgery. The company’s product and technology portfolio continued to broaden in 2023 and 2024. Predict was presented as an AI-based assessment tool for identifying patients who may be at risk of musculoskeletal surgery and directing them toward non-surgical care. Atlas extended pain-management resources internationally, and Academy supplied educational material. On-Call offered access to clinical specialists, while Phoenix used natural-language processing and computer vision to provide more immediate therapy feedback. Sword also introduced Outcome Pricing, a commercial model in which payment is linked to treatment outcomes. Sword reported international operations and offices in the United States, Ireland, and Portugal by 2024. It has raised more than $340 million according to the supplied reference material, with a reported $3 billion valuation after its 2024 funding round. These figures describe private-company financing and valuation rather than public-market capitalization. The company also faced challenges associated with scaling a technology-assisted care model. In October 2024, it reduced its workforce by 17%, including treatment-facing clinicians, citing efficiency and scalability. The restructuring prompted discussion about the effect of AI and workflow automation on digital-health staffing. In 2025, Sword acquired Surgery Hero, a United Kingdom digital-health company focused on prehabilitation before surgery. The acquisition expanded Sword’s offering into preparation for procedures and was followed by reported partnerships with 18 NHS trusts. Sword’s present positioning is therefore broader than a virtual physical therapy provider: it presents a connected digital-care platform spanning prevention, rehabilitation, pain management, pelvic health, surgery-risk reduction, and prehabilitation, with AI integrated into clinical workflows and patient exercise experiences.
History
Sword Health was established in Portugal in 2015 by Virgílio Bento and Márcio Colunas. Its early work combined biomedical engineering, wearable motion sensing, and software intended to support rehabilitation outside a conventional clinic. The company’s initial proposition was that movement data and artificial intelligence could supplement the work of physical therapists by monitoring exercises, identifying performance patterns, and giving patients structured guidance between clinical interactions. A prototype system combining wearable sensors with an AI-enabled digital therapy platform was introduced in 2016. In 2017, Sword conducted a feasibility study examining AI-assisted rehabilitation and motor-task performance. These efforts helped establish the technical and clinical basis for a service that could deliver guided therapy remotely. By 2018, the company had begun pilots outside Portugal and secured financing to support expansion, including the creation of a U.S. office. Recognition at the 2019 UCSF Digital Health Awards, in the Employer Wellness & Prevention category, helped raise the profile of its digital musculoskeletal offering. Sword’s expansion accelerated between 2020 and 2022. It raised new capital to develop the platform, grow its clinical organization, and establish relationships with employers and health plans. During this period, the company worked on a program intended to identify people at elevated risk of surgery and direct them toward conservative treatment where appropriate. This reflected a broader strategic position: digital therapy could be offered not only as a convenience but also as an intervention designed to reduce pain, improve function, and potentially affect downstream healthcare utilization. The company broadened its clinical categories during the same period. Its Thrive offering remained associated with musculoskeletal therapy, while Move addressed movement health and injury prevention. In March 2022, Sword launched Bloom for pelvic health, including postpartum recovery and pelvic-floor dysfunction. This expansion made the platform relevant to a wider range of conditions and life stages than general orthopedic rehabilitation alone. In 2023, Sword introduced Predict, an AI-based tool intended to assess musculoskeletal surgery risk and identify non-surgical options. The company also reported research concerning patient engagement, clinical outcomes, and intent to undergo surgery. Toward the end of the year it launched Atlas, a pain-management platform described as being available in 150 countries, together with Academy, an educational resource, and On-Call, a service providing around-the-clock access to clinical specialists. In 2024, Phoenix added real-time feedback capabilities using natural-language processing and computer vision. Sword also introduced Outcome Pricing, a payment approach designed to connect commercial charges more closely to treatment results. The company’s growth was accompanied by operational pressure. In October 2024, Sword reduced its workforce by 17%, including clinicians who worked directly with patients. Management attributed the restructuring to efficiency and scalability. The reduction occurred against a wider digital-health trend in which companies were using AI to automate or streamline parts of clinical operations, while also raising questions about the appropriate balance between automation and human care. Sword continued to expand geographically and clinically. By 2024, it operated internationally and had offices in the United States, Ireland, and Portugal. In 2025, it acquired Surgery Hero, a UK company specializing in prehabilitation before surgery. The transaction extended Sword’s model into the period before a procedure, when exercise, education, and preparation may support recovery. Following the acquisition, the company was reported to have partnered with 18 NHS trusts in the United Kingdom. Sword has also encountered legal and financing-related scrutiny. A2 Academy filed a lawsuit in July 2024 alleging that it was owed a 5% ownership stake under an agreement associated with Sword’s participation in an accelerator program in 2014–2015. The supplied material does not establish the outcome of that litigation. Financing reported through 2024 exceeded $340 million, and a Series E round was associated with a private valuation of approximately $3 billion. Sword remains a private digital-health company whose identity is defined by AI-supported rehabilitation, employer and health-plan distribution, and an expanding set of programs covering prevention, therapy, pain, pelvic health, and surgical preparation.
- 2025
Surgery Hero acquired
[1]The acquisition expands Sword into digital prehabilitation and surgical preparation in the United Kingdom.
- 2024
Phoenix and Outcome Pricing introduced
[1]Sword adds AI-enabled real-time therapy feedback and a payment model linked to treatment outcomes.
- 2024
Workforce restructuring
[1]Sword reduces its workforce by 17% while citing efficiency and scalability objectives.
- 2023
Predict, Atlas, Academy, and On-Call expand the platform
[1]Sword adds surgery-risk assessment, pain management, education, and specialist-access services.
- 2022
Bloom launches
[1]Sword enters pelvic health with Bloom, targeting pelvic-floor conditions and postpartum recovery.
- 2021
Series C and Series D financing
[1]The company completes major financing rounds and reaches a reported private valuation of approximately $2 billion.
- 2020
Series A and platform expansion
[1]Sword raises reported Series A capital to advance its AI therapy platform and expand clinical operations.
- 2019
UCSF Digital Health Awards recognition
[1]Sword receives recognition for its employer wellness and prevention-oriented digital musculoskeletal therapy.
- 2018
International pilots and U.S. expansion begin
[1]The company launches pilots outside Portugal and establishes a U.S. presence as it raises expansion capital.
- 2017
Feasibility study of AI-assisted rehabilitation
[1]Sword evaluates the use of AI-supported rehabilitation for motor-task performance.
Products and positioning
An AI-enabled digital physical therapy and rehabilitation platform distributed through employers, health plans, and healthcare systems, with an emphasis on measurable outcomes, non-surgical care, and digitally supported clinical services.
Musculoskeletal digital therapy
Thrive
Thrive is Sword’s core digital musculoskeletal therapy offering. It uses guided exercises, digital monitoring, clinical support, and sensor-based movement feedback to help people manage common orthopedic and movement-related conditions. The program is generally positioned for distribution through employers and health plans, with the goal of improving function and reducing pain while helping members access care remotely.
Pelvic health · 2022
Bloom
Bloom is Sword’s pelvic-health program, launched in 2022. It is designed for conditions involving pelvic-floor function and related symptoms, including support for postpartum recovery. The program extends Sword’s digital therapy approach beyond general musculoskeletal care through guided treatment, education, and remote clinical support.
Injury prevention and movement health
Move
Move focuses on movement quality, injury prevention, and maintaining physical health before a condition requires formal rehabilitation. It broadens Sword’s model from treatment of existing pain or impairment toward preventive and workplace-oriented programs intended to help users move safely and manage physical risk.
Surgery-risk assessment · 2023
Predict
Predict is an AI-based tool introduced in 2023 to assess a person’s risk of musculoskeletal surgery and help identify potential non-surgical care pathways. It reflects Sword’s effort to use data and clinical decision support earlier in the care journey, before a patient proceeds to an invasive intervention.
Pain management · 2023
Atlas
Atlas is a pain-management platform launched at the end of 2023 and described as available in 150 countries. It combines clinically validated exercises with educational resources intended to help users understand and manage pain through a digital care experience.
Health education · 2023
Academy
Academy is Sword’s digital education platform focused on pain management and related health knowledge. It complements therapy programs by giving users explanatory material and practical information intended to support adherence, self-management, and informed participation in care.
Clinical support · 2023
On-Call
On-Call provides access to clinical specialists around the clock. It adds a human clinical-access layer to Sword’s software and exercise programs, allowing users to obtain support beyond scheduled or automated interactions.
AI therapy feedback · 2024
Phoenix
Phoenix is an AI-powered feature released in 2024. It uses natural-language processing and computer vision to provide real-time feedback during therapy, illustrating Sword’s strategy of integrating machine intelligence into the exercise and coaching experience.
Prehabilitation
Surgery Hero
Surgery Hero is a UK digital-health business acquired by Sword in 2025. Its focus is prehabilitation: helping patients prepare physically and educationally for surgery with the aim of supporting better recovery after the procedure.
Controversies
2024
A2 Academy ownership-stake lawsuit
A2 Academy sued Sword Health in July 2024, alleging that an agreement connected to Sword’s participation in an accelerator program during 2014–2015 entitled A2 to a 5% ownership stake. The supplied reference material does not establish the litigation’s resolution.
Marketing campaigns
- 2024World Changing Ideas Awards recognition
International
Sword was recognized by Fast Company’s World Changing Ideas Awards for innovation in digital healthcare.
Outcome. The award provided external recognition for Sword’s technology-enabled healthcare model.
- 2019UCSF Digital Health Awards recognition
United States
Sword’s digital musculoskeletal therapy solution received recognition in the Employer Wellness & Prevention category at the UCSF Digital Health Awards.
Outcome. The recognition supported the company’s visibility in employer-sponsored digital health and prevention.
Brand decisions
2025
Acquisition of Surgery HeroM&ABackground
Sword was expanding from rehabilitation and pain management into the period before surgery.
Action taken
The company acquired Surgery Hero, a UK provider focused on digital prehabilitation.
Aftermath
Sword subsequently partnered with 18 NHS trusts to integrate digital prehabilitation services into UK healthcare programs.
2024
Introduction of PhoenixProduct launchBackground
Sword continued integrating artificial intelligence into remote therapy interactions.
Action taken
The company released Phoenix, using natural-language processing and computer vision to provide real-time therapy feedback.
Aftermath
Phoenix strengthened the platform’s emphasis on automated, sensor- and camera-assisted coaching.
2024
Adoption of Outcome PricingStrategyBackground
Digital health providers increasingly sought commercial models tied to demonstrable clinical value.
Action taken
Sword introduced Outcome Pricing, a payment model that adjusts costs according to treatment outcomes.
Aftermath
The model aligned Sword’s commercial positioning with measurable results, although the supplied material does not provide detailed contract terms or financial results.
2024
Workforce restructuring for efficiency and scalabilityStrategyBackground
Sword stated that it needed to improve efficiency and scalability as its digital care model developed.
Action taken
The company reduced its workforce by 17%, including treatment-facing clinicians.
Aftermath
The restructuring reduced staffing and reflected the sector-wide shift toward greater use of AI in clinical workflows.
2023
Launch of Predict for surgery-risk assessmentProduct launchBackground
Musculoskeletal patients may face surgery even when conservative care could be appropriate.
Action taken
Sword introduced an AI-based tool intended to identify surgery risk and potential non-surgical options.
Aftermath
The product positioned Sword earlier in the musculoskeletal care pathway.
2022
Expansion into pelvic health with BloomProduct launchBackground
Sword sought to extend its digital therapy model beyond general musculoskeletal conditions.
Action taken
The company launched Bloom for pelvic-floor conditions and postpartum recovery support.
Aftermath
Bloom became part of Sword’s broader multi-condition digital therapy portfolio.
Recent events
Solera Health launches musculoskeletal offering[2]
Reported:
Solera Health launched a new musculoskeletal offering through digital therapy solutions from SWORD Health, Kaia Health, and Sworkit.
Navitus Health Solutions partners with SWORD Health[3]
Reported:
Navitus Health Solutions announced a partnership with SWORD Health to bring its virtual musculoskeletal solution to Navitus clients and their plan members nationwide.
Sword Health raises $85 million[4]
Reported:
Sword Health raised $85 million in funding from investors, bringing its total funding to date to $135 million.
SWORD Health appoints Karin Ajmani to its board[5]
Reported:
SWORD Health announced the appointment of Karin Ajmani to its Board of Directors.
SWORD Health launches SessionBot[6]
Reported:
SWORD Health announced the launch of SessionBot, a virtual event aggregator that brings together sessions from employee benefits and digital health conferences and standalone vendor sessions.
SWORD Health wins UCSF Digital Health Award[7]
Reported:
SWORD Health won first prize at the 2019 UCSF Digital Health Awards in the Employer Wellness & Prevention category.
Sources7 sources
- 1Sword Healthen.wikipedia.org
- 2Solera Health 推出肌肉骨骼健康服务ptproductsonline.com
- 3Navitus Health Solutions与SWORD Health达成合作ptproductsonline.com
- 4Sword Health 获得 8500 万美元融资ptproductsonline.com
- 5SWORD Health任命Karin Ajmani加入董事会prnewswire.com
- 6SWORD Health 推出 SessionBotptproductsonline.com
- 7SWORD Health获UCSF数字健康奖ptproductsonline.com
Cite this profile: Cite the canonical profile. /brand-wiki/sword-health · Editorial policy · How profiles are compiled